On August 9, Maryland’s Prescription Drug Affordability Board (PDAB) released its draft action plan for establishing upper payment limits (UPLs) for drugs identified as causing or likely to cause affordability challenges. The...more
8/22/2024
/ Draft Guidance ,
Drug Pricing ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medicare ,
Out-of-Pocket Expenses ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Underpayment